Fred Hutch at AACR: New targets for cancer therapies

 Experts from Fred Hutchinson Cancer Center will present their latest findings on targets in RIT1-driven cancers, ROR1 CAR T-cell immunotherapy, interplay of the microbiome and genetics in colorectal cancer and more at the annual meeting of the American Association for Cancer Research, to be held April 14-19 in Orlando, Florida. 

Other meeting highlights include:

Philip Greenberg, M.D. of Fred Hutch will become AACR president.

Public health researcher and biostatistician Ruth Etizioni, Ph.D. will discuss new and emerging tests for early detection of cancer.

Christopher Li, M.D., MPH, a national leader in diversity, equity and inclusion efforts at cancer centers, will best practices and strategies to enhance diversity. 

https://www.newswise.com/articles/fred-hutch-at-aacr-new-targets-for-cancer-therapies-experts-available-in-diversity-and-cancer-screening-tests-and-fred-hutch-s-philip-greenberg-becomes-aacr-president